The future of healthcare is at the home - we are a team of technologists building the next generation of medical products at the intersection of hardware and software. We won’t stop until we’ve brought the world class tools of a hospital to your home.

We develop hardware & software and diagnostics to improve the lives of chronic care patients (cancer, hypertension, schizophrenia, bipolar disorder).

In the US, 80% of healthcare spend occurs in 20% of patients. We aim to drastically reduce this cost through modern software, hardware, and preventative care services. Its core device (FDA Class 2 cleared) uses machine-learning trained on cell classification to allow chronic patients to monitor their white blood count at home. Its core software product is a platform to help doctors monitor vitals, trends, etc. of such patients, so that physicians and patients can stay aligned without direct interaction.

We've raised $132 million at a $1.5 billion valuation from top tier investors such as General Catalyst, Sequoia Capital, Y Combinator, and Initialized.